Speakers
Nick Traggis
Founder & Chief Executive Officer
Ambrosia Biosciences
Aimee Raleigh
Principal
Atlas Venture
Andrew Whittle
Global Head, Cardio-Renal-Metabolic BD&L
Boehringer Ingelheim
Robrecht Thoonen
Senior Director, External Innovation, Diabetes, Obesity & Cardiometabolic Diseases
Eli Lilly & Company
Ashley Zehnder
Founder & Chief Executive Officer
Fauna Bio
Clare Bernard
Venture Partner
F-Prime
Anthony Philippakis
General Partner
GV
Jordan Shin
Chief Medical Officer
HAYA Therapeutics
Jens Eckstein
Investment Partner && Member of the Board of Advisors
Hevolution Foundation & Apollo Health Ventures
Rajiv Patni
Chief Executive Officer
Judo Bio
Chris Lu
Chief Executive Officer
Laekna Therapeutics
Kasper Veje
Vice President, Head of Diabetes & Obesity Search & Evaluation
Novo Nordisk
Sam Murphy
Chief Executive Officer
SalubrusBio
Marc Abrams
Chief Technology Officer & Head of US Operations
SanegeneBio
Philip Just Larsen
Chief Executive Officer
SixPeaks Bio
Alicia Irurzun-Lafitte
Partner
UCB Ventures
David Moller
Chief Scientific Officer
Variant Bio
Jason Ruth
Sector Lead, Biotech Private Investments
Wellington Management